Drawing for Serial No. 79309668

USPTO serial 79309668

Serial No. 79309668

Reviewed by CopyMark Law Group

Reg. 6674615Status 700Registered
Filing date
Status date
Registration date
Mar 22, 2022
Examiner
POLZER, NATALIE M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79309668?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roger D. Emerson, Esq.

Roger D. Emerson, Esq. Emerson Thomson Bennett1914 Akron-Peninsula RoadAkron, OH 44313UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemical catalysts; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations other than for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals for treating breast cancer or diabetes, which refers to namely, the raw drug materials used in the production of various preparations, are the effective ingredients in the preparations, and the powders, crystals and extracts prepared by chemical synthesis, plant extraction or biotechnology, are used for medicinal purposes, but the substances cannot be taken by patientsACTIVE—
005Diagnostic preparations for veterinary purposes; amino acids for veterinary purposes; chemical preparations for treating mildew; chemical reagents for medical or veterinary purposes; chemical preparations for pharmaceutical or medical purposes, namely, for breast cancer or diabetes and liposome pharmaceutical reagents for mRNA vaccines; biological preparations for the treatment of breast cancer or diabetes; guaiacol for pharmaceutical purposes; chemico-pharmaceutical preparations for the prevention and treatment of cancer or diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 17, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 17, 2022FIMPFINAL DISPOSITION PROCESSED—
Jun 22, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 22, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 10, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jan 4, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 4, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 22, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 22, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2021RFNTREFUSAL PROCESSED BY IB—
Dec 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 3, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2021DOCKASSIGNED TO EXAMINER—
Jul 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 22, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 22, 2021RFRRREFUSAL PROCESSED BY MPU—
Jun 12, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2021DOCKASSIGNED TO EXAMINER—
May 4, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 29, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance